血管生成
新生血管
血管内皮生长因子A
血管内皮生长因子
视网膜
炎症
视网膜病变
免疫印迹
内分泌学
医学
内科学
癌症研究
生物
眼科
生物化学
血管内皮生长因子受体
基因
糖尿病
作者
Jieqiong Zhang,Zhifei Liu,Haoqian Wu,Xi Chen,Qiumei Hu,Xue Li,Luo Lu,Shiyang Ye,Jian Ye
摘要
Purpose: Abnormal angiogenesis is a defining feature in a couple of ocular neovascular diseases. The application of anti-VEGFA therapy has achieved certain benefits in the clinic, accompanying side effects and poor responsiveness in many patients. The present study investigated the role of irisin in retinal neovascularization. Methods: Western blot and quantitative PCR were used to determine irisin expression in the oxygen-induced retinopathy mice model. The pathological angiogenesis and inflammation index were examined after irisin administration. Primary retinal astrocytes were cultured and analyzed for VEGFA expression in vitro. Astrocyte-conditioned medium was collected for transwell assay and tube formation assay in human microvascular endothelial cells-1. Results: Irisin was downregulated in the oxygen-induced retinopathy mice retinae. Additional irisin attenuated pathological angiogenesis, inflammation, and apoptosis in vivo. In vitro, irisin decreased astrocyte VEGFA production, and the conditioned medium suppressed human microvascular endothelial cells-1 migration. Last, irisin inhibited hypoxia-inducible factor-2α, nuclear factor-κB, and pNF-κB (Phospho-Nuclear Factor-κB) expression. Conclusions: Irisin mitigates retinal pathological angiogenesis. Chinese Abstract
科研通智能强力驱动
Strongly Powered by AbleSci AI